Basal cell carcinoma is caused primarily by ultraviolet radiation damaging the DNA in skin cells. With nearly 2 million cases diagnosed annually in the United States alone, it is the most common form of skin cancer. While UV exposure is the dominant driver, several other factors, from genetics to chemical exposures, can also trigger or accelerate its development.
How UV Light Damages Skin Cell DNA
When ultraviolet light hits your skin, it doesn’t just cause a sunburn. It physically alters the structure of your DNA. UVB rays (the ones most responsible for burning) cause adjacent DNA building blocks called pyrimidines to fuse together, forming abnormal bonds that the cell wasn’t designed to handle. These fused pairs, known as pyrimidine dimers, are the single most relevant type of DNA damage for skin cancer development.
UVA rays, the longer-wavelength light that penetrates deeper into the skin and passes through windows, can cause the same type of damage but requires a much higher dose to do so. UVA also contributes through a different route: it triggers the formation of oxidized DNA bases through a process involving reactive oxygen molecules. So both types of UV light are harmful, just through slightly different mechanisms. Over years, this accumulating damage overwhelms your cells’ ability to repair themselves, and mutations begin to stick.
The Genetic Switch That Controls Growth
Most basal cell carcinomas share a common molecular problem: a broken tumor-suppression system called the Hedgehog signaling pathway. In healthy skin, a gene called PTCH1 acts as a brake on cell growth. It keeps a growth-promoting protein called Smoothened in check. When UV damage or an inherited mutation knocks out PTCH1, that brake releases, and the pathway floods the cell with signals to divide.
This isn’t a subtle effect. When PTCH1 loses its inhibitory function, it triggers a cascade of growth-promoting proteins that push the cell toward becoming a tumor. Germline (inherited) mutations in PTCH1 are responsible for Gorlin syndrome, a rare condition that causes people to develop dozens or even hundreds of basal cell carcinomas, often starting around age 20 or even in childhood. But in the vast majority of cases, the PTCH1 mutation is acquired over a lifetime of UV exposure rather than inherited.
Fair Skin and Other Physical Risk Factors
Your skin’s natural pigmentation is one of the strongest predictors of basal cell carcinoma risk. People with Fitzpatrick skin types I and II, those who burn easily and rarely tan, carry the greatest susceptibility. This is because melanin, the pigment that gives skin its color, absorbs UV radiation before it reaches the DNA in deeper skin cells. Less melanin means less built-in protection.
Light eye color and light hair color further correlate with increased risk, largely because these traits track with lower overall melanin production. These characteristics don’t cause basal cell carcinoma on their own, but they reduce the margin of error when it comes to sun exposure.
Sunburn History and Exposure Patterns
For years, researchers debated whether intermittent sun exposure (weekend sunburns, beach vacations) or chronic occupational exposure (working outdoors for decades) was the bigger threat for basal cell carcinoma. Earlier studies leaned toward intermittent exposure as the primary culprit for BCC, while chronic exposure was linked more to squamous cell carcinoma. More recent evidence suggests the picture is less tidy.
A case-control study found that a history of blistering sunburn nearly doubled the risk of BCC, with an odds ratio of 1.96. But working in the sun for 10 years or longer carried a comparable risk increase, with an odds ratio of 2.14. The takeaway: both patterns of exposure contribute. A single severe sunburn in your twenties and decades of moderate daily exposure can both leave lasting DNA damage in basal cells.
Indoor Tanning
Tanning beds concentrate UV radiation, and the earlier you start using them, the more damage accumulates during a period when skin cells are still actively developing. Any history of indoor tanning is associated with a 69% increased risk of early-onset basal cell carcinoma. Starting before age 16 pushes the risk even higher, with an 83% increase compared to people who never used tanning beds. These are not small numbers, and they help explain why dermatologists see BCC increasingly in people in their twenties and thirties.
Radiation Therapy and Ionizing Radiation
UV light isn’t the only type of radiation that causes basal cell carcinoma. Ionizing radiation, the kind used in cancer treatment and medical imaging, also damages DNA in ways that promote BCC. Data from the Childhood Cancer Survivor Study found a clear dose-response relationship: for every unit increase in radiation dose, the odds of developing BCC rose proportionally. Children who received high-dose radiation therapy (35 Gy or more) had nearly 40 times the risk of developing BCC later in life compared to survivors who weren’t treated with radiation.
Historical evidence reinforces this pattern. Before antifungal medications became available in the 1950s, roughly 200,000 children worldwide received X-ray treatments for a scalp fungal infection called tinea capitis. Follow-up studies spanning decades found these patients developed BCC at roughly 3 to 5 times the rate of unexposed populations. Notably, BCC was the primary type of skin cancer driven by the radiation, while rates of other skin cancers weren’t significantly altered.
Weakened Immune System
Your immune system constantly patrols for abnormal cells and destroys them before they can multiply into tumors. When that surveillance system is suppressed, precancerous cells that would normally be eliminated get a chance to grow. Organ transplant recipients, who take immunosuppressive drugs for life to prevent rejection, face six times the risk of developing basal cell carcinoma compared to the general population. Other forms of immune suppression, including from HIV or certain medications, similarly raise BCC risk, though the transplant data is the most well-documented.
Arsenic Exposure
Chronic exposure to inorganic arsenic is one of the few non-radiation environmental causes of basal cell carcinoma. The most common sources are contaminated drinking water and occupational exposure in industries like agriculture and mining. Vineyard workers with prolonged skin and inhalation exposure to arsenic-based pesticides have shown excess mortality rates from arsenic-induced skin cancer.
What makes arsenic-related BCC distinctive is its presentation. These tumors tend to arise from otherwise normal-looking skin rather than from precancerous lesions, they’re almost always multiple, and they frequently appear on the trunk rather than sun-exposed areas like the face. The latency period is remarkably long: skin cancers linked to arsenic ingestion typically don’t appear until three to four decades after exposure, making the connection easy to miss. Epidemiological studies show a clear dose-response relationship between arsenic levels in drinking water and skin cancer prevalence.
Gorlin Syndrome and Inherited Risk
Gorlin syndrome, also called nevoid basal cell carcinoma syndrome, is a rare inherited condition caused by germline mutations in the PTCH1 gene. Rather than acquiring a PTCH1 mutation through decades of sun exposure, people with Gorlin syndrome are born with one defective copy. It takes only a single additional hit to the remaining functional copy for a tumor to develop, which is why these patients develop BCCs far earlier and in far greater numbers than the general population.
The median age for developing the first BCC in Gorlin syndrome is 20 years, though some patients present in infancy. Diagnosis requires the presence of specific clinical criteria, including multiple BCCs (or a single BCC before age 20), jaw cysts confirmed by biopsy, distinctive pitting on the palms or soles, and certain skeletal abnormalities. A first-degree relative with the syndrome is itself a major diagnostic criterion, reflecting the autosomal dominant inheritance pattern. While Gorlin syndrome accounts for only a small fraction of all BCC cases, it illustrates how central the PTCH1 pathway is to this cancer’s biology.